-
Resumos de Teses10-13-2000
Nível plasmático de tamoxifeno e resposta tumoral de pacientes com câncer avançado de mama
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):55-55
Abstract
Resumos de TesesNível plasmático de tamoxifeno e resposta tumoral de pacientes com câncer avançado de mama
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):55-55
DOI 10.1590/S0100-72032000000100010
Views48Nível Plasmático de Tamoxifeno e Resposta Tumoral de Pacientes com Câncer Avançado de Mama […]See more
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Resumos de Teses10-13-2000
Efeito de uma ação educativa sobre a conduta dos profissionais de saúde da rede de atenção primária em relação às doenças de transmissão sexual
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):55-55
Abstract
Resumos de TesesEfeito de uma ação educativa sobre a conduta dos profissionais de saúde da rede de atenção primária em relação às doenças de transmissão sexual
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):55-55
DOI 10.1590/S0100-72032000000100011
Views48Efeito de uma Ação Educativa sobre a Conduta dos Profissionais de Saúde da Rede de Atenção Primária em Relação às Doenças de Transmissão Sexual […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article10-13-2000
Clinical and metabolic aspects of postmenopausal women treated with tibolone
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):37-41
Abstract
Original ArticleClinical and metabolic aspects of postmenopausal women treated with tibolone
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):37-41
DOI 10.1590/S0100-72032000000100007
Views78See morePurpose: to evaluate the effects of tibolone on climacteric symptoms and clinical and metabolic variables. Methods: thirty-four postmenopausal women were treated orally with 2.5 mg tibolone daily for 48 weeks and evaluated as to climacteric complaints, clinical aspects such as weight and blood pressure and lipid profile (total cholesterol, HDL-c, LDL-c, VLDL-c and triglycerides). Results: a significant improvement of climacteric complaints was demonstrated by a significant decrease in the Kupperman index (p<0.001) and the mean number of hot flushes (p<0.001) from the first month of treatment onwards. There was a significant decrease in total cholesterol, triglycerides and VLDL-c (p<0.001). The LDL-c levels presented a slight decrease (not significant). The HDL-c levels showed a significant decrease at week 24. However these levels returned to baseline levels at week 48. With regard to the vital signs no change in body weight and blood pressure was measured. The side effects were mild and temporary, vaginal bleeding, nausea and edema being the most common. Conclusion: tibolone may be considered a safe and efficient option to treat climacteric symptoms in postmenopausal women without significant impact on lipid profile.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article10-13-2000
Effects of tamoxifen and conjugated estrogens on the mammary epithelium of rats in persistent estrus
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):33-36
Abstract
Original ArticleEffects of tamoxifen and conjugated estrogens on the mammary epithelium of rats in persistent estrus
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):33-36
DOI 10.1590/S0100-72032000000100006
Views133See morePurpose: to evaluate the morphologic and morphometric alterations produced by tamoxifen and conjugated estrogens in the mammary epithelium of rats in persistent estrus. Methods: thirty-three adult female rats in persistent estrus induced with 1.25 mg testosterone propionate were divided at random into three groups: GI — which received only water, control group (n = 12); GII — treated with 500 mug tamoxifen daily (n = 10); GIII — treated with 30 mug conjugated estrogens per day (n = 11). The first inguinal-abdominal pair of mammary glands of the animals was extirpated and processed for morphologic and morphometric study. Data were analyzed statistically by the Kruskal-Wallis rank analysis of variance (p < 0.05). Results: the morphologic study revealed signs of epithelial atrophy and the morphometric study showed a statistically significant reduction in the mean number of ducts and alveoli in groups II (10.1 and 1.9, respectively) and III (11.1 and 3.5, respectively) compared to group I (25.0 and 6.6, respectively). There was no significant difference between groups II and III. Conclusions: the results of this study indicate that tamoxifen as well as conjugated estrogens at the tested doses produced mammary epithelial atrophy in rats in persistent estrus.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article10-13-2000
Is it safe to withold magnesium sulfate in preeclamptic women?
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):13-17
Abstract
Original ArticleIs it safe to withold magnesium sulfate in preeclamptic women?
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):13-17
DOI 10.1590/S0100-72032000000100003
Views70See morePurpose: to determine magnesium sulfate effectiveness to prevent eclamptic seizures in pregnant women diagnosed with preeclampsia. Methods: a case-control study involving 489 pregnant patients admitted to the Hospital de Clínicas de Porto Alegre (HCPA) with the diagnosis of hypertension between January 1990 and January 1997. The patients were divided into two groups: those who received magnesium sulfate (Group I) and those who did not (Group II). All patients were treated according to the hospital’s standard protocol for the treatment of hypertensive pregnant women. The following variables were assessed: maternal age, race, number of seizures, number of seizures in patients receiving magnesium sulfate, period of magnesium sulfate administration, before and after delivery, maternal mortality, need of ICU care, need of mechanical ventilation and length of hospital stay after delivery. Data were assessed with Epi-Info 6.0 statistical package, using multivariate analysis. The main outcome measure was magnesium sulfate use. Results: no differences were found between the two groups in terms of maternal age, race or gestational age. Women who received magnesium sulfate had a higher mean systolic and diastolic blood pressure. Women in the intervention group had a longer hospital stay and a greater need of ICU care. Need of mechanical ventilation and maternal mortality were similar in the two groups. Twenty-two out of 353 women had one or more seizures before admission to the hospital. Six women (27.3%) had one or two additional seizures after magnesium sulfate administration. No subjects had three or more seizures after receiving magnesium sulfate. Conclusion: the results show that eclamptic seizures can be prevented by routine prophylactic magnesium sulfate administration.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article10-13-2000
Diagnostic capacity of oligohydramnios by ultrasound using different measures of the maximum pool depth of amniotic fluid in comparison to AFI
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):7-12
Abstract
Original ArticleDiagnostic capacity of oligohydramnios by ultrasound using different measures of the maximum pool depth of amniotic fluid in comparison to AFI
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):7-12
DOI 10.1590/S0100-72032000000100002
Views123See morePurpose: to compare the capacity of diagnosing oligohy-dramnios by ultrasound using different measures of the maximum pool depth of amniotic fluid in comparison to the amniotic fluid index among normal pregnant women from the 36th to the 42nd week of gestation. Methods: a descriptive study of diagnostic validity was perfomed, on 875 normal pregnant women who were studied through routine obstetric ultrasound examinations, including the measure of the maximum pool depth for the diagnosis of oligohydramnios, using the amniotic fluid index as the gold standard. The data were analyzed through sensitivity and specificity of the maximum pool depth of amniotic fluid using 10, 20 and 30 mm cut-offs, in comparison to the amniotic fluid index values of the normal curve in percentiles 2.5 and 10 for different gestational ages. Results: the maximum pool depth had a poor sensitivity to diagnose oligohydramnios when 10 and 20 mm were used as cut-offs, and good sensitivity and specificity when 30 mm was used, in comparison to the amniotic fluid values in percentiles 2.5 and 10. The best sensitivity and specificity of the maximum pool depth were when found using a 30 mm cut-off in comparison to 2.5 percentile to diagnose oligohydramnios. Conclusions: the capacity to diagnose oligohydramnios by the measure of the maximum pool depth is satisfactory only with the cut-off of 30 mm
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Femina, RBGO e o ano 2000
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(1):6-6
Abstract
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Resumos de Teses10-10-2000
Distribuição de Macrófagos, Linfócitos T e Linfócitos B em Vilosidades Placentárias de Gravidezes Humanas a Termo
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(2):119-119
Abstract
Resumos de TesesDistribuição de Macrófagos, Linfócitos T e Linfócitos B em Vilosidades Placentárias de Gravidezes Humanas a Termo
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(2):119-119
DOI 10.1590/S0100-72032000000200015
Views49Distribuição de Macrófagos, Linfócitos T e Linfócitos B em Vilosidades Placentárias de Gravidezes Humanas a Termo […]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Search
Search in:
Tag Cloud
Pregnancy (252)Breast neoplasms (104)Pregnancy complications (104)Risk factors (103)Menopause (88)Ultrasonography (83)Cesarean section (78)Prenatal care (71)Endometriosis (70)Obesity (61)Infertility (57)Quality of life (55)prenatal diagnosis (51)Women's health (48)Postpartum period (46)Maternal mortality (45)Pregnant women (45)Breast (44)Prevalence (43)Uterine cervical neoplasms (43)